E-LIB Suche - Ergebnisse für: Bamias, A.

1

New prognostic model in patients with advanced urothelial c..:

Bamias, A ; Merseburger, A ; Loriot, Y...
ARTN e005977. , 2023

Link: https://repository.icr.a..

2

P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATM..:

T. Thomopoulos ; A. Bouchla ; A. Antoniadou...
http://journals.lww.com/10.1097/01.HS9.0000849372.14120.8e. , 2022

Link: https://doi.org/10.1097/..

3

Baseline neutrophil-to-lymphocyte ratio as a predictive and..:

de Wit, R ; Wülfing, C ; Castellano, D...
100241. , 2022

Link: https://repository.icr.a..

4

Predictive biomarkers for survival benefit with ramucirumab..:

van der Heijden, MS ; Powles, T ; Petrylak, D...
https://eprints.whiterose.ac.uk/186635/1/Predictive%20biomarkers%20for%20survival%20benefit%20with%20ramucirumab%20in%20urothelial%20cancer%20in%20the%20RANGE%20trial.pdf. , 2022

Link: https://eprints.whiteros..

5

P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATM..:

Thomopoulos, T ; Bouchla, A ; Antoniadou, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431122/. , 2022

Link: http://www.ncbi.nlm.nih...

6

Referral for "Neoadjuvant Chemotherapy" for Muscle-Invasive..:

Dellis A ; Zakopoulou R ; Kougioumtzopoulou A...
https://www.dovepress.com/referral-for-neoadjuvant-chemotherapy-for-muscle-invasive-bladder-canc-peer-reviewed-fulltext-article-CMAR. , 2021

Link: https://doaj.org/article..

7

Baseline neutrophil-to-lymphocyte ratio as a predictive and..:

de Wit, R ; Wülfing, C ; Castellano, D...
de Wit , R , Wülfing , C , Castellano , D , Kramer , G , Eymard , J C , Sternberg , C N , Fizazi , K , Tombal , B , Bamias , A , Carles , J , Iacovelli , R , Melichar , B , Sverrisdóttir , Theodore , C , Feyerabend , S , Helissey , C , Foster , M C , Ozatilgan , A , Geffriaud-Ricouard , C & de Bono , J 2021 , ' Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study ' , ESMO Open , vol. 6 , no. 5 , 100241 . https://doi.org/10.1016/j.esmoop.2021.100241. , 2021

Link: https://pure.eur.nl/en/p..

8

PIVOT-10: Phase II study of bempegaldesleukin plus nivoluma..:

Huddart R.A ; Siefker-Radtke A.O ; Balar A.V...
Future Oncology. , 2021

Link: https://doi.org/10.2217/..

9

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothe..:

Bajorin, D.F ; Witjes, J.A ; Gschwend, J.E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215888/. , 2021

Link: http://www.ncbi.nlm.nih...

10

Baseline neutrophil-to-lymphocyte ratio as a predictive and..:

de Wit, R ; Wülfing, C ; Castellano, D...
info:eu-repo/grantAgreement/Sanofi Genzyme//. , 2021

Link: http://hdl.handle.net/20..

11

Baseline neutrophil-to-lymphocyte ratio as a predictive and..:

de Wit, R ; Wülfing, C ; Castellano, D...
info:eu-repo/grantAgreement/Sanofi Genzyme//. , 2021

Link: http://hdl.handle.net/20..

12

Baseline neutrophil-to-lymphocyte ratio as a predictive and..:

de Wit, R ; Wülfing, C ; Castellano, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390550/. , 2021

Link: http://www.ncbi.nlm.nih...

13

A subgroup analysis from the IMvigor130 study in patients w..:

A. Bamias ; M. De Santis ; E. Grande...
http://www.sciencedirect.com/science/article/pii/S2666168320361668. , 2020

Link: https://doi.org/10.1016/..

14

PIVOT-10: Phase II study of bempegaldesleukin plus nivoluma..:

Huddart, RA ; Siefker-Radtke, AO ; Balar, AV...
Future oncology (London, England), 2020. , 2020

Link: https://repository.icr.a..

15

Axitinib as a third or further line of treatment in renal c..:

Tsironis, G ; Liontos, M ; Kyriazoglou, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265645/. , 2020

Link: http://www.ncbi.nlm.nih...